John R. Prensner

Active 2007–2026

Also published as
John R Prensner
56
Papers
21,270
Citations
38
h-index
49
i10-index

Citations

Citations per year for John R. Prensner1985: 1 citations2001: 1 citations2002: 1 citations2004: 2 citations2006: 3 citations2007: 2 citations2008: 37 citations2009: 58 citations2010: 125 citations2011: 180 citations2012: 266 citations2013: 378 citations2014: 376 citations2015: 460 citations2016: 534 citations2017: 477 citations2018: 464 citations2019: 1,186 citations2020: 1,091 citations2021: 914 citations2022: 555 citations2023: 387 citations2024: 652 citations2025: 292 citations2026: 32 citations1986–2000: no citations, so these years are not shown2003: no citations, so this year is not shown2005: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,071 citing papers, 26.7% of this breakdownChina: 2,499 citing papers, 21.7% of this breakdownUnited Kingdom: 623 citing papers, 5.4% of this breakdownGermany: 499 citing papers, 4.3% of this breakdownCanada: 445 citing papers, 3.9% of this breakdownItaly: 354 citing papers, 3.1% of this breakdownAustralia: 300 citing papers, 2.6% of this breakdownSpain: 277 citing papers, 2.4% of this breakdownJapan: 258 citing papers, 2.2% of this breakdownFrance: 256 citing papers, 2.2% of this breakdownSwitzerland: 217 citing papers, 1.9% of this breakdownNetherlands: 209 citing papers, 1.8% of this breakdown
0%26.7%Other 21.8%

Fields

  • Biochemistry, Genetics and Molecular Biology69.8%
  • Medicine26.2%
  • Immunology and Microbiology1%
  • Agricultural and Biological Sciences0.8%
  • Computer Science0.5%
  • Chemistry0.5%
  • Other1.2%

Topics

  • Cancer-related molecular mechanisms research12.6%
  • RNA modifications and cancer7.9%
  • RNA Research and Splicing5.1%
  • Prostate Cancer Treatment and Research4.6%
  • Cancer Genomics and Diagnostics4%
  • Circular RNAs in diseases4%
  • Other61.8%

Coauthors

All papers

Open in search
  1. The landscape of somatic copy-number alteration across human cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth A. Maher, Frederic J. Kaye, Hidefumi Sasaki, Joel E. Tepper, Jonathan A. Fletcher, Josep Tabernero, José Baselga, Ming‐Sound Tsao, Francesca Demichelis, Mark A. Rubin, Pasi A. Jänne, Mark J. Daly, Carmelo Nucera, Ross L. Levine, Benjamin L. Ebert, Stacey Gabriel, Anil K. Rustgi, Cristina R. Antonescu, Marc Ladanyi, Anthony Letai, Levi A. Garraway, Massimo Loda, David G. Beer, Lawrence D. True, Aikou Okamoto, Scott L. Pomeroy, Samuel Singer, Todd R. Golub, Eric S. Lander, Gad Getz, William R. Sellers, Matthew Meyerson - Nature 2010 cited by 4,185

  2. The landscape of long noncoding RNAs in the human transcriptome

    Authors: , , , , , , , , , , , , , , , , , , - Nature Genetics 2015 cited by 2,890

  3. The mutational landscape of lethal castration-resistant prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2012 cited by 2,607

  4. Standardized annotation of translated open reading frames

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Uwe Ohler, Xavier Roucou, Alan Saghatelian, Jonathan S. Weissman, Sebastiaan van Heesch - Nature Biotechnology 2022 cited by 250

  5. Evolutionary origins and interactomes of human, young microproteins and small peptides translated from short open reading frames

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Molecular Cell 2023 cited by 160

  6. Noncanonical open reading frames encode functional proteins essential for cancer cell survival

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2021 cited by 195

  7. What Can Ribo-Seq, Immunopeptidomics, and Proteomics Tell Us About the Noncanonical Proteome?

    Authors: , , , , , , , , , - Molecular & Cellular Proteomics 2023 cited by 91

  8. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2011 cited by 1,035

  9. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2013 cited by 683

  10. Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Molecular Cell 2024 cited by 67

  11. The Emergence of lncRNAs in Cancer Biology

    Authors: , - Cancer Discovery 2011 cited by 1,818

  12. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William R. Sellers - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 1,086

  13. PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma

    Authors: , , , , , , , , , , - Cancer Research 2012 cited by 293

  14. The Long Non-Coding RNA PCAT-1 Promotes Prostate Cancer Cell Proliferation through cMyc

    Authors: , , , , , , , , , , , , - Neoplasia 2014 cited by 254

  15. Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Valerie P. Castle, Raymond J. Hutchinson, Moshe Talpaz, Dan R. Robinson, Arul M. Chinnaiyan - JAMA 2015 cited by 416

  16. Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer

    Authors: , , , , , , , , , , , - Neoplasia 2008 cited by 700

  17. Beyond PSA: The Next Generation of Prostate Cancer Biomarkers

    Authors: , , , - Science Translational Medicine 2012 cited by 475

  18. Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2017 cited by 255

  19. PCAT-1 , a Long Noncoding RNA, Regulates BRCA2 and Controls Homologous Recombination in Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2014 cited by 253

  20. Targeting the MLL complex in castration-resistant prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2015 cited by 216

  21. High-quality peptide evidence for annotating non-canonical open reading frames as human proteins

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah A. Slavoff, Eivind Valen, Aaron Wacholder, Jonathan S. Weissman, Wei Wu, Zhi Xie, Jyoti S. Choudhary, Michal Bassani‐Sternberg, Juan Antonio Vizcaíno, Nicola Ternette, Robert L. Moritz, John R. Prensner, Sebastiaan van Heesch - 2024 cited by 35

  22. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 cited by 270

  23. KRAS-G12C Mutation Is Associated with Poor Outcome in Surgically Resected Lung Adenocarcinoma

    Authors: , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2014 cited by 141

  24. The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2016 cited by 275